GoToHealth Radio’s Jonathan Marx recently interviewed BeCare Link’s Chief Medical Officer Charisse D. Litchman, exploring the features and benefits of the remote patient monitoring enabled by the BeCare MS Link. The weekly show features in-depth interviews with health experts from around the world, educating its viewers and listeners on relevant health topics. Distributed on VoiceAmerica, […]
In 2021, BeCare App was granted FDA approval for marketing to US users without additional regulatory requirements. The BeCare MS Link mobile app is available to the general public, including all activities, questionnaires, and healthcare provider features. The unique app received Class I classification in 2021. However, the proprietary EDSS scoring is currently only available
BeCare Link Cleared for FDA-Class I Classification Read More »
Artificial Intelligence can predict disease progression. Here is the words of BeCare Link’s CEO in May 2019 of what the future holds for the BeCare Link apps. To watch the video, click the button below. BeCare Link is an artificial intelligence digital therapeutic company. We’re focused on multiple sclerosis and fall risk to start with.
BeCare Link App: AI Helps Monitor Disease Progression – May 2019 Read More »
One of the New MS Treatments: Perfect App for Anyone Living with Multiple Sclerosis MyTherapy rated three apps as ideal for people living with MS in June of 2018. The conclusion: BeCare Link is a perfect app, and is one of the new MS treatments. The author Dan Brown elaborates below: “If you are living
BeCareLink voted best app for tracking MS progress – June 2018 Read More »
BeCare Link has created a mobile application (“BeCare MS Link” in the Google Play app store) that connects patients to physicians and researchers to provide unprecedented levels of insight into multiple sclerosis (MS) and other neurodegenerative diseases. As paraphrased from a MS patient: “Much of MS is what is happening in your head, and you
BeCare Link’s Innovative App for Multiple Sclerosis Patients – May 2018 Read More »
